DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
FRA:DBAN - Deutsche Boerse Ag - DE000A1TNUT7 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to DBAN. DBAN was compared to 102 industry peers in the Capital Markets industry. Both the profitability and the financial health of DBAN get a neutral evaluation. Nothing too spectacular is happening here. DBAN is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DBAN had positive earnings in the past year.
DBAN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DBAN reported negative net income in multiple years.
In multiple years DBAN reported negative operating cash flow during the last 5 years.
1.2 Ratios
DBAN has a better Return On Assets (5.20%) than 75.24% of its industry peers.
Looking at the Return On Equity, with a value of 6.90%, DBAN is in the better half of the industry, outperforming 60.95% of the companies in the same industry.
DBAN's Return On Invested Capital of 4.00% is fine compared to the rest of the industry. DBAN outperforms 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.2% | ||
| ROE | 6.9% | ||
| ROIC | 4% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DBAN has a Profit Margin of 43.72%. This is amongst the best in the industry. DBAN outperforms 89.52% of its industry peers.
DBAN's Profit Margin has declined in the last couple of years.
The Operating Margin of DBAN (45.84%) is better than 87.62% of its industry peers.
In the last couple of years the Operating Margin of DBAN has declined.
DBAN's Gross Margin of 95.08% is amongst the best of the industry. DBAN outperforms 97.14% of its industry peers.
DBAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45.84% | ||
| PM (TTM) | 43.72% | ||
| GM | 95.08% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
DBAN has less shares outstanding than it did 1 year ago.
DBAN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DBAN has a worse debt to assets ratio.
2.2 Solvency
DBAN has an Altman-Z score of 2.72. This is not the best score and indicates that DBAN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.72, DBAN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Debt to FCF ratio of DBAN is 11.27, which is on the high side as it means it would take DBAN, 11.27 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 11.27, DBAN is doing good in the industry, outperforming 74.29% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that DBAN is not too dependend on debt financing.
The Debt to Equity ratio of DBAN (0.20) is better than 78.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 11.27 | ||
| Altman-Z | 2.72 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 4.62 indicates that DBAN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.62, DBAN belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
A Quick Ratio of 4.62 indicates that DBAN has no problem at all paying its short term obligations.
DBAN has a better Quick ratio (4.62) than 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.62 | ||
| Quick Ratio | 4.62 |
3. Growth
3.1 Past
DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.94%.
The Earnings Per Share has been decreasing by -3.13% on average over the past years.
The Revenue for DBAN has decreased by -30.08% in the past year. This is quite bad
DBAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)-56.94%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%325.91%
Revenue 1Y (TTM)-30.08%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%462.22%
3.2 Future
Based on estimates for the next years, DBAN will show a decrease in Earnings Per Share. The EPS will decrease by -9.23% on average per year.
The Revenue is expected to decrease by -3.20% on average over the next years.
EPS Next Y-37.04%
EPS Next 2Y-9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.45 indicates a reasonable valuation of DBAN.
Based on the Price/Earnings ratio, DBAN is valued cheaply inside the industry as 83.81% of the companies are valued more expensively.
DBAN is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.11 indicates a reasonable valuation of DBAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DBAN indicates a rather cheap valuation: DBAN is cheaper than 92.38% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, DBAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.45 | ||
| Fwd PE | 8.11 |
4.2 Price Multiples
71.43% of the companies in the same industry are more expensive than DBAN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.58 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DBAN's earnings are expected to decrease with -9.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.23%
EPS Next 3YN/A
5. Dividend
5.1 Amount
DBAN has a Yearly Dividend Yield of 3.88%. Purely for dividend investing, there may be better candidates out there.
DBAN's Dividend Yield is a higher than the industry average which is at 6.34.
Compared to an average S&P500 Dividend Yield of 2.33, DBAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.88% |
5.2 History
The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.57% of the earnings are spent on dividend by DBAN. This is a low number and sustainable payout ratio.
DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP39.57%
EPS Next 2Y-9.23%
EPS Next 3YN/A
FRA:DBAN (3/7/2025, 7:00:00 PM)
25.3
-0.5 (-1.94%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners13.48%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap475.64M
Analysts90
Price Target42.47 (67.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.88% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP39.57%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.18%
PT rev (3m)-4.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-48.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-22.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.45 | ||
| Fwd PE | 8.11 | ||
| P/S | 4.38 | ||
| P/FCF | 38.58 | ||
| P/OCF | 36.46 | ||
| P/B | 0.69 | ||
| P/tB | 0.75 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.42
EY9.57%
EPS(NY)3.12
Fwd EY12.32%
FCF(TTM)0.66
FCFY2.59%
OCF(TTM)0.69
OCFY2.74%
SpS5.78
BVpS36.61
TBVpS33.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.2% | ||
| ROE | 6.9% | ||
| ROCE | 5.68% | ||
| ROIC | 4% | ||
| ROICexc | 4.85% | ||
| ROICexgc | 5.23% | ||
| OM | 45.84% | ||
| PM (TTM) | 43.72% | ||
| GM | 95.08% | ||
| FCFM | 11.35% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.14%
ROICexcg growth 5Y-8.15%
ROICexc growth 3Y-37.69%
ROICexc growth 5Y-9.49%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 11.27 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.66% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 25.95% | ||
| Current Ratio | 4.62 | ||
| Quick Ratio | 4.62 | ||
| Altman-Z | 2.72 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.94%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%325.91%
EPS Next Y-37.04%
EPS Next 2Y-9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.08%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%462.22%
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-53.88%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year45.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.54%
OCF growth 3YN/A
OCF growth 5YN/A